Tech Company Financing Transactions
Synvect Funding Round
Antler, Bill & Melinda Gates Foundation and NuFund Venture Group participated in a $3 million funding round for Synvect. The funding round was announced on 3/11/2025.
Transaction Overview
Company Name
Announced On
3/11/2025
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to accelerate the development and deployment of its CRISPR-based technology, offering an eco-friendly solution to suppress disease-carrying mosquito populations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5838 Agee Street
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
A biotechnology platform to develop safe, scalable, and effective solutions to eliminate disease-transmitting vectors, starting with the world's deadliest animal: the mosquito.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nikolay Kandul
Chief Scientific Officer
Omar Akbari
Co-Founder
Ravi Solanki
VP - Bus. Development
Pooja Patel
Browse more venture capital transactions:
Prev: 3/11/2025: pgEdge venture capital transaction
Next: 3/11/2025: Reveleum venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs